• contact
  • |
  • site map
  • |
  • careers
 
  • Home
  • About Us
    • Overview
    • Executive Team
    • Board of Directors
    • Collaborations
    • Mission
    • Corporate History
    • Advisors
  • Technology
    • Overview
    • Innovation @ Chikujee
    • Focused Diversification
    • Drug Development
    • Advantages
    • Personalized Healthcare
    • Clinical Trials
  • Products
    • Overview
    • Autism
    • Targeted Therapeutics
    • Biomarker Monitoring
    • Personalized Products
  • Investors
    • Overview
    • Investment Highlights
    • IP Strategy
    • Business Strategy
    • Investor Contacts
  • News & Events
    • News
    • Events
    • Corporate Fact Sheet
    • Corporate Library
    • Media Contacts
    • Join Mailing List
  • Careers
    • Overview
    • Culture
    • Diversity
    • Job Opportunities

Home › Overview › Efficient Drug Development
  • Overview
  • Innovation @ Chikujee
  • Focused Diversification
  • Efficient Drug Development
  • Technology Advantages
  • Personalized Healthcare
  • Clinical Trials


 

Chikujee Technology

 

THE Aayush personalized Health care PLATFORM

 

Efficient Drug Development

Powerful convergence of innovative technologies and their seamless integration and implementation will provide the mission critical need of making the drug development process more efficient in terms of time to market and consistent quality of the new life science products. The correct use of these tools will not only help make drug development more efficient but will also help reduce enormous cost of drug development.

key elements of long term growth and revenue sustainability

A.   Large market that is ready for a change and is looking for an innovative approach.

B.   The diagnostics, treatment and clinical monitoring command premium reimbursements from patients as well as insurers.

C.   Aayush Technology platform uses proprietary NanoBindi that provides

§  Simplicity of Design

§  Lower tactical risk-development, manufacturing, regulatory approval as well as investment

§  Meaningful barriers for competition

§  First mover advantage

§  New level of adoption by patients

D.  A multifunctional product development that offers

§  A Patient: a simple patient-friendly product that ensures therapy compliance.

§  Company: significantly reduces development timelines, ensures consistent quality and is regulatory agency friendly

E.   Provides an alternative personalized medicine product portfolio that eliminates privacy concerns, is relatively inexpensive, easy to scale up.

 

© 2012 Chikujee Therapeutics | Privacy Policy | Terms of Use | Join Mailing List